Pseudomoans among most virulent of corneal pathogens

Guttman, Cheryl
March 2009
Ophthalmology Times;3/15/2009, Vol. 34 Issue 6, p47
Trade Publication
The article discusses the diagnostic and treatment options for Pseudomonas keratitis. Therapeutic options cited include fluoroquinolones, antibiotics and the combination of monotherapy and a second-generation fluoroquinolone. It also addressed the impact of the emergence of bacterial infections, like methicillin-resistant Staphylococcus aureus (MRSA) and Acanthamoeba, which were more difficult to treat than Pseudomonas keratitis.


Related Articles

  • In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone. Cong-Ran Li; Yi Li; Guo-Qing Li; Xin-Yi Yang; Wei-Xin Zhang; Ren-Hui Lou; Jing-Fang Liu; Min Yuan; Shan Cen; Li-Yan Yu; Li-Xun Zhao; Jian-Dong Jiang; Xue-Fu You; Philip Huang // Journal of Antimicrobial Chemotherapy (JAC);Nov2010, Vol. 65 Issue 11, p2411 

    Objectives To evaluate the in vivo antibacterial efficacy of nemonoxacin, a novel C8-methoxy non-fluorinated quinolone in murine systemic and local infection models. Methods The efficacy of nemonoxacin in systemic infections was evaluated in mouse peritonitis models using isolates of...

  • SUSCEPTIBILITY TRENDS OF PSEUDOMONAS SPECIES FROM CORNEAL ULCERS. Smitha, S.; Lalitha, P.; Prajna, V. N.; Srinivasan, M. // Indian Journal of Medical Microbiology;Jul2005, Vol. 23 Issue 3, p168 

    Purpose: To assess the changing trends in the antibiotic susceptibility of Pseudomonas spp. isolated from bacterial keratitis over a nine year period with special emphasis on fluoroquinolone susceptibilities. Methods: All corneal scraping cultures positive for Pseudomonas spp. (n=585) isolated...

  • Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus.  // BMC Microbiology;2011, Vol. 11 Issue 1, p241 

    The article focuses on a study conducted to analyze the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus. To characterize the efflux activity of 52 S. aureus isolates resistant to ciprofloxacin, several methodologies were used. In 12 out...

  • Nephrology/pediatric nephrology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS64 

    Presents an abstract of the research manuscript `Use of intraperitoneal fluoroquinolone to replace vancomycin in the treatment of staph. aureus peritonitis and exit-site infections in a rabbit model of peritoneal dialysis,' by M.K. Dasgupta and M. Larabie.

  • Multidrug-Resistant Streptococcus pneumoniae Infections:Current and Future Therapeutic Options. Van Bambeke, Françoise; Reinert, René R.; Appelbaum, Peter C.; Tulkens, Paul M.; Peetermans, Willy E. // Drugs;2007, Vol. 67 Issue 16, p2355 

    Antibacterial resistance in Streptococcus pneumoniae is increasing worldwide, affecting principally ß-lactams and macrolides (prevalence ranging between ≈1% and 90% depending on the geographical area). Fluoroquinolone resistance has also started to emerge in countries with high level of...

  • A practical guide to the fluoroquinolones. D'Epiro, Peter; Cheng, Cynthia // Patient Care;1/15/2002, Vol. 36 Issue 1, p20 

    Presents an approach to the appropriate use of quinolones. Description of the anti-bacterial action of fluoroquinolones; Classification; Adverse effects.

  • New Classification and Update on the Quinolone Antibiotics. King, Dana E.; Malone, Robb; Lilley, Sandra H. // American Family Physician;5/1/2000, Vol. 61 Issue 9, p2741 

    Presents an update on quinolone antibiotics. Overview of fluoroquinolones; Classification of quinolones; Cost of fluoroquinolone therapy.

  • Fluoroquinolone misuse in ER creates concern. Pfeiffer, Naomi // Dermatology Times;Jul2001, Vol. 22 Issue 7, p1 

    Cites research findings on the misuse of fluoroquinolone antibiotics in emergency rooms. Inappropriate dispensing of the antibiotic to patients; Impact of antibiotic misuse on the emergence of fluoroquinolone resistance; Need for a more vigorous campaign to educate physicians.

  • Fluoroquinolones in Paediatrics. Gendrel, D.; Moulin, F. // Pediatric Drugs;2001, Vol. 3 Issue 5, p365 

    The fluoroquinolones are an important group of antibiotics, which are widely used in adult patients because of their high penetration in tissues and bactericidal activity. However, they are not licensed for paediatric use (except the limited indication of Pseudomonas infection in cystic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics